JORVEZA

This brand name is authorized in Austria, Canada, Croatia, Estonia, Finland, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, UK.

Active ingredients

The drug JORVEZA contains one active pharmaceutical ingredient (API):

1	Budesonide UNII Q3OKS62Q6X - BUDESONIDE
	Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.
	Read more about Budesonide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07EA06	Budesonide	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EA Corticosteroids acting locally
Discover more medicines within A07EA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02493675
EE	Ravimiamet	1762567, 1762578, 1762589, 1762590, 1762602, 1819144, 1819166, 1819177, 1819188, 1819199
FI	Lääkealan turvallisuus- ja kehittämiskeskus	183893, 536762
GB	Medicines & Healthcare Products Regulatory Agency	357748
IL	מִשְׂרַד הַבְּרִיאוּת	8511
IT	Agenzia del Farmaco	045928013, 045928025, 045928037, 045928049, 045928052, 045928064, 045928076, 045928088, 045928090, 045928102, 045928114
LT	Valstybinė vaistų kontrolės tarnyba	1084796, 1084797, 1084798, 1084799, 1084800, 1090331, 1090332, 1090333, 1090334, 1090335, 1090336
NZ	Medicines and Medical Devices Safety Authority	22153, 22154
PL	Rejestru Produktów Leczniczych	100400890, 100443310